Perspective Therapeutics ...

AMEX: CATX · Real-Time Price · USD
3.84
-0.06 (-1.54%)
At close: Aug 15, 2025, 10:05 AM

Perspective Therapeutics Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Jun 30, 2022
Revenue
n/a 1.43M 7.1M 10.79M
Cost of Revenue
n/a n/a 5.47M 6.18M
Gross Profit
n/a 1.43M 1.63M 4.62M
Operating Income
10.46M -40.94M -15.18M -7.39M
Interest Income
10.52M 934K 1.12M 119K
Pretax Income
-81.38M -40.11M -14.67M -7.27M
Net Income
-79.28M -46.51M -14.67M -7.15M
Selling & General & Admin
26.61M 21.06M 14.21M 9.43M
Research & Development
41.64M 21.31M 2.6M 2.58M
Other Expenses
24.09M n/a n/a n/a
Operating Expenses
92.34M 42.38M 17.43M 12.01M
Interest Expense
-48K 84K n/a 119K
Selling & Marketing Expenses
n/a 97K 3.23M 2.8M
Cost & Expenses
n/a 42.38M 22.9M 18.19M
Income Tax Expense
-2.1M -2.65M n/a -119K
Shares Outstanding (Basic)
64.42M 54.91M 54.91M 54.91M
Shares Outstanding (Diluted)
64.42M 54.91M 54.91M 54.91M
EPS (Basic)
-1.23 -0.85 -0.27 -0.13
EPS (Diluted)
-1.23 -0.85 -0.27 -0.13
EBITDA
10.46M -39.96M -14.84M -7.39M
EBIT
-81.42M -40.94M -15.18M n/a
Depreciation & Amortization
n/a 981K 344K 248K